ISTOCK.COM, MEDITERRANEAN A couple of years ago, I interviewed a patient who suffered from an aggressive form of prostate cancer to discuss his clinical trials. In this context, he mentioned how an increasingly popular immunotherapy seemed out of reach for him because it worked well for blood cancers but hit a wall when it came to solid tumors. Keeping a pulse on basic research allows one to witness the birth of ingenious ideas and the development of cutting-edge technologies, some of which might change